Press Releases
STAINES-UPON-THAMES, United Kingdom, March 4, 2020 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a global biopharmaceutical company, today announced fin
Read more...BOSTON, March 4, 2020 /PRNewswire/ -- Biofourmis, a global leader in digital therapeutics that powers personalized predictive care, announced today that its technology is being leveraged in a remote
Read more...CHICAGO, March 4, 2020 /PRNewswire/ -- Longtime workers' compensation executive Ryan Kelly has joined managed care firm Rising Medical Solutions (Rising) as Vice President of Business Development. In this role, Ryan will direct client acquisition efforts with a focus on expanding Rising's clinical services footprint, in addi
Read more...ST. LOUIS, March 4, 2020 /PRNewswire/ -- Express Scripts today announced a new program to bring simplicity, affordability, and predictability to HIV prevention through increased education and appropriate use of pre-exposure prophylaxis (PrEP) treatments. The HIV Care ValueSM program is the industry's first value-based program to help prevent the transmission
Read more...NORTH CHICAGO, Ill., March 4, 2020 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of March 2, 2020 its issued share capital, excluding treasury shares, is comprised of 1,482,464,688 shares of common stock with a par value of $0.01
Read more...4 March 2020
ROCKVILLE, Md. and SANTA CLARA, Calif., March 4, 2020 /PRNewswire/ -- DrFirst, a pioneer in technology, support, and services that connect people at touchpoints of patie
Read more...SAN JOSE, Calif., March 4, 2020 /PRNewswire/ -- Aridis Pharmaceuticals, Inc. (Nasdaq: ARDS), a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening bacterial infections, is pleased to provide an update on its Investor Day being held on Thursday, March 12th
Read more...STOCKHOLM, March 4, 2020 /PRNewswire/ -- Cinclus Pharma Holding AB ("Cinclus Pharma") announced today that the company has successfully completed a financing round of SEK 250 million to fund the further clinical development of X842 – a clinical-stage drug candidate for the treatment of gastroesophageal reflux disease
Read more...FARMINGTON HILLS, Mich., March 4, 2020 /PRNewswire/ -- Centria Autism, a leading national provider of Applied Behavior Analysis (ABA) therapy for children with autism, and Team Armani Racing have announced they are teaming up for the 2020 NASCAR racing season. Centria Autism will be a primary sponsor of Team Armani, supporting 19-year-old driver
Read more...MIAMI, March 4, 2020 /PRNewswire/ -- ArisGlobal, a leading provider of life sciences software that automates core drug development functions for over 250 life sciences companies, is thrilled to announce their participation at the World Drug Safety Congress A
Read more...